A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)

Trial ID or NCT#

NCT04207983

Status

not recruiting iconNOT RECRUITING

Purpose

The objective of the study is to evaluate the efficacy and safety of two different treatment regimens of EYS606.

Official Title

A 48 Week Phase II, Randomized, Open-Label, Multicenter, Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Quan Dong Nguyen, MD, MSc
Quan Dong Nguyen, MD, MSc
Ophthalmologist, Retina specialist, Uveitis and ocular inflammation specialist
Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)

View on ClinicalTrials.gov